Monashee Investment Management LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 64 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Monashee Investment Management LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$223,000
-43.0%
65,0560.0%0.15%
+81.9%
Q3 2018$391,00065,0560.08%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders